SCHEMBL25201520

SCHEMBL25201520

CC(C)(C)C(=O)N(O)Cc1ccc(Nc2ccccc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 2/20 0.55
MAPT P10636 5/20 0.48
GAA P10253 2/20 0.48
HPGD P15428 2/20 0.48
RAB9A P51151 1/20 0.48
POLB P06746 2/20 0.44
ALOX5 P09917 1/20 0.43
PTGS1 P23219 1/20 0.43
PTGS2 P35354 1/20 0.43
CASP3 P42574 1/20 0.42
SENP7 Q9BQF6 1/20 0.42
ALDH1A1 P00352 1/20 0.42
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
RECQL P46063 1/20 0.41
MTOR P42345 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26154407 0.93 RIPK1 (0.51) RIPK1MAPTGAAHPGDRAB9A
SCHEMBL25193629 0.87 RIPK1 (0.76) RIPK1MAPTGAAHPGDRAB9A
SCHEMBL25203723 0.87 RIPK1 (0.62) RIPK1MAPTGAAHPGDRAB9A
SCHEMBL25203434 0.87 RIPK1 (0.44) RIPK1GAARAB9APOLBALDH1A1
SCHEMBL25194563 0.87 RIPK1 (0.44) RIPK1MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL7800481 0.85 RIPK1 (0.72) RIPK1RAB9APOLBALOX5PTGS1
SCHEMBL25191135 0.85 MAPT (0.43) RIPK1MAPTGAAHPGDRAB9A
SCHEMBL25188300 0.85 RIPK1 (0.43) RIPK1MAPTRAB9APOLBSMN1; SMN2
SCHEMBL25205621 0.85 NPC1 (0.43) RIPK1RAB9ACASP3SENP7MEN1
SCHEMBL25203785 0.85 NR1H4 (0.42) RIPK1MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115151252-B Iron death inhibitor-diarylamine acetamides 维泰瑞隆有限公司 2024-08-27 CN disclosed
US-20230159492-A1 FERROPTOSIS INHIBITORS - DIARYLAMINE PARA-ACETAMIDES Sironax Ltd. (KY) 2023-05-25 US disclosed
US-20230159492-A1 FERROPTOSIS INHIBITORS - DIARYLAMINE PARA-ACETAMIDES Sironax Ltd. (KY) 2023-05-25 US disclosed
US-20230159492-A1 FERROPTOSIS INHIBITORS - DIARYLAMINE PARA-ACETAMIDES Sironax Ltd. (KY) 2023-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159492-A1 FERROPTOSIS INHIBITORS - DIARYLAMINE PARA-ACETAMIDES AIFM2, FECH, GPX4 RIPK1 474/4885MAPT 4384/4885GAA 4193/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.